Organic lithium salts

Lithium Acetate 98.0+%, TCI America™

CAS: 546-89-4 Molecular Formula: C2H3LiO2 Molecular Weight (g/mol): 65.98 MDL Number: MFCD00013057 InChI Key: XIXADJRWDQXREU-UHFFFAOYSA-M Synonym: lithium acetate,lithium ethanate,quilone,acoli,acetic acid, lithium salt,lithium ethanoate,lithium 1+ ion acetate,lioac,unii-h4278o5flv,acetic acid lithium salt PubChem CID: 3474584 ChEBI: CHEBI:63045 IUPAC Name: lithium(1+) acetate SMILES: [Li+].CC([O-])=O

Lithium Pyruvate Monohydrate 95.0+%, TCI America™

CAS: 2922-61-4 Molecular Formula: C3H3LiO3 Molecular Weight (g/mol): 93.994 MDL Number: MFCD00036136 InChI Key: OFJHGWPRBMPXCX-UHFFFAOYSA-M Synonym: lithium pyruvate,lithium 2-oxopropanoate,pyruvic acid lithium salt,propanoic acid, 2-oxo-, lithium salt,lithiumpyruvat,lithotab 2-oxopropanoate,propanoic acid, 2-oxo-, lithium salt 1:1,c3h3o3.li,lithium pyruvate h2o,lithium 1+ pyruvate PubChem CID: 23663618 IUPAC Name: lithium;2-oxopropanoate SMILES: [Li+].CC(=O)C(=O)[O-]

Medchemexpress LLC Mevalonic acid lithium salt | 2618458-93-6 | 98.0% | 154.09 | 10 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

Mevalonic acid (MVA) lithium salt is a precursor substance of the mevalonate pathway, which is essential for cell growth and proliferation. It is effective in inhibiting Simvastatin-induced decrease in C2C12 cell viability in vitro. Mevalonic acid lithium salt can be used in studies of myopathy and heart failure.

• Precursor substance of the mevalonate pathway.
• Essential for cell growth and proliferation.
• Effective in inhibiting Simvastatin-induced decrease in C2C12 cell viability in vitro.
• Can be used in studies of myopathy and heart failure.
• High purity.
• Available in solid and solution forms.
• Supported by multiple publications citing its use.

Medchemexpress LLC Cholan-24-oic acid, 3-[(2S)-2-amino-3-carboxy-1-oxopropoxy]-, (3α,5β)- | 881179-02-8 | 98.0% | 491.66 | 50 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

Lith-O-Asp is a sialyltransferase (ST) inhibitor with IC50s ranging from 12-37 μM. It has been shown to decrease the activity of both a-2,3- and a-2,6-sialyltransferases, inhibiting the transfer of sialic acids to targeted glycoproteins. Research indicates that Lith-O-Asp can suppress FAK/paxillin signaling, as well as cancer angiogenesis and metastasis pathways. It has demonstrated an ability to reduce lung metastases in animal models.

• Sialyltransferase (ST) inhibitor
• IC50s of 12-37 μM
• Suppresses FAK/paxillin signaling
• Inhibits cancer angiogenesis and metastasis pathways
• Decreases activity of a-2,3- and a-2,6-sialyltransferases
• Inhibits transfer of sialic acids to targeted glycoproteins
• Reduces lung metastases in vivo

Medchemexpress LLC Cholan-24-oic acid, 3-[(2S)-2-amino-3-carboxy-1-oxopropoxy]-, (3α,5β)- | 881179-02-8 | 98.0% | 491.66 | 10 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

Lith-O-Asp is a sialyltransferase (ST) inhibitor with IC50 values ranging from 12-37 μM. It has been shown to decrease the activity of both α-2,3- and α-2,6-sialyltransferases, thereby inhibiting the transfer of sialic acids to targeted glycoproteins. Research indicates that Lith-O-Asp may suppress cancer angiogenesis and metastasis pathways, as demonstrated by fewer lung metastases in treated mice compared to controls.

• Sialyltransferase (ST) inhibitor.
• Inhibits the activities of ST3Gal I, ST3Gal III, and ST6GalI.
• Decreases expression of cell surface α-2,3- and α-2,6-sialylated antigens.
• Suppresses cancer angiogenesis and metastasis pathways.

Medchemexpress LLC Cholan-24-oic acid, 3-[(2S)-2-amino-3-carboxy-1-oxopropoxy]-, (3α,5β)- | 881179-02-8 | 98.0% | 491.66 | 25 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

Lith-O-Asp is a sialyltransferase (ST) inhibitor, with IC50 values ranging from 12-37 μM against ST3Gal I, ST3Gal III, and ST6GalI. It inhibits α-2,3- and α-2,6-sialyltransferases, decreasing sialic acid transfer to targeted glycoproteins. Research shows potential in suppressing cancer angiogenesis and metastasis, with treated mice exhibiting fewer lung metastases in a 4T1-Luc breast cancer model.

• Sialyltransferase (ST) inhibitor
• IC50 values of 12-37 μM against ST3Gal I, ST3Gal III, and ST6GalI
• No apparent growth inhibition effect on different cancer cell lines at tested doses (10, 30, and 60 μM)
• Decreases expression of cell surface α-2,3- and α-2,6-sialylated antigens
• Suppresses FAK/paxillin signaling and cancer angiogenesis and metastasis pathways in vivo

Medchemexpress LLC Lith-O-Asp | 881179-02-8 | MFCD31692386 | 98.0% | 491.66 g/mol | C28H45NO6 | 5 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

Lith-O-Asp is a small-molecule sialyltransferase (ST) inhibitor reported to inhibit ST activity with IC50 values of 12-37 μM. It is provided as a purified research reagent in solid form for biochemical and cell-based studies; not for human therapeutic use.

• Inhibits sialyltransferase with IC50 12-37 μM.
• High purity (98.0%).
• Molecular formula C28H45NO6 and molecular weight 491.66 g/mol.
• Supplied as a solid in milligram quantities suitable for screening and assays.
• Intended for research use only; not for therapeutic applications.
• CAS number 881179-02-8 for unambiguous identification.

Medchemexpress LLC Lith-O-Asp | 881179-02-8 | 98.0% | 491.66 | 100 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

Lith-O-Asp is a sialyltransferase (ST) inhibitor with IC50s of 12-37 μM. It inhibits the activities of ST3Gal I, ST3Gal III, and ST6GalI, decreasing the expression of cell surface α-2,3- and α-2,6-sialylated antigens.

• Inhibits sialyltransferase (ST) activities with IC50 values ranging from 12 to 37 μM.
• Decreases the activity of both α-2,3- and α-2,6-sialyltransferases.
• Inhibits the transfer of sialic acids to targeted glycoproteins.
• Shows no apparent growth inhibition effect toward different cancer cell lines at tested doses.
• Leads to fewer lung metastases in treated mice.
• Decreases average tumor nodules per mouse in vivo.

Lithium DL-2-Hydroxybutyrate 98.0+%, TCI America™

CAS: 381716-41-2 Molecular Formula: C4H7LiO3 Molecular Weight (g/mol): 110.037 MDL Number: MFCD00040991 InChI Key: CILZBARDXHWUSX-UHFFFAOYSA-M Synonym: DL-2-Hydroxybutyric Acid Lithium Salt PubChem CID: 23707041 IUPAC Name: lithium;2-hydroxybutanoate SMILES: [Li+].CCC(C(=O)[O-])O